Drug intelligence / Profile preview

vedicinals9

Development stage
Unknown
Lead developer
Vedicinals
Modality
Small Molecules
Administration
Oral
01

Overview

Vedicinals®9 is a polyherbal nutraceutical formulation containing nine bioactive plant-derived molecules: Baicalin, Quercetin, Luteolin, Rutin, Hesperidin, Curcumin (from turmeric), Epigallocatechin gallate (EGCG), Piperine, and Glycyrrhizin. It is supplemented with vitamins and minerals such as Vitamin C (L-ascorbic acid), D3, E (D-alpha tocopherol oil), B1/B2/B5/B6/B12 complex, zinc, selenium, coconut oil and olive oil. The product is designed to provide anti-inflammatory and antioxidant support while promoting immune health. It acts by downregulating pro-inflammatory cytokines (e.g., TNF-α) and oxidative stress markers, inhibiting cancer cell proliferation/migration in vitro, and modulating host cellular pathways disrupted by viral infections such as SARS-CoV-2. It has been studied in clinical trials for COVID-19 as an adjuvant therapy showing improved recovery rates compared to standard care. The formulation is vegan-friendly and manufactured under stringent quality standards.

Brand names
Vedicinals®9Vedicinals®9 Advanced
Other names
Vedicinals-9Vedicinals9Vedicinals 9VEDICINALS®️9

Beyond the preview

Go deeper on vedicinals9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vedicinals9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call